Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (241-250 of 375) with videos related to

Pageof 38
Sort By:
The Lancet. Oncology|April 30, 2026
CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trialsMohammed S Beshr, Ammar Fahaid, Rana H Shembesh, et al.
BMC Cancer|May 21, 2017
The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patientsMatteo Lambertini, Paola Anserini, Valeria Fontana, et al.
JAMA|January 1, 2016
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical TrialMatteo Lambertini, Luca Boni, Andrea Michelotti, et al.
Cancer Treatment Reviews|February 5, 2023
Germline TP53 pathogenic variants and breast cancer: A narrative reviewEva Blondeaux, Luca Arecco, Kevin Punie, et al.
JCO Oncology Practice|October 9, 2025
Comprehensive Diagnostic and Therapeutic Approaches for Estrogen Receptor-Low Breast Cancer: A Multidisciplinary Perspective From Oncologists and PathologistsPaola Zagami, Andrea Botticelli, Isabella Castellano, et al.
British Journal of Cancer|November 2, 2016
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patientsMatteo Lambertini, Ana Catarina Pinto, Lieveke Ameye, et al.
Journal of the National Cancer Institute|December 1, 2021
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer PatientsMatteo Lambertini, Luca Boni, Andrea Michelotti, et al.
Breast Cancer Research and Treatment|April 28, 2025
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trialChristian Maurer, Elisa Agostinetto, Lieveke Ameye, et al.
Oncology Research and Treatment|December 6, 2022
Career and Professional Development for Young OncologistsMaximilian J Mair, Claudia Cardone, Liz Connolly, et al.
Breast (Edinburgh, Scotland)|November 22, 2017
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancerSamuel Martel, Elena Poletto, Arlindo R Ferreira, et al.
Pageof 38

Showing results (241-250 of 375) with videos related to

Sort By:
Pageof 38
The Lancet. Oncology|April 30, 2026
CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trialsMohammed S Beshr, Ammar Fahaid, Rana H Shembesh, et al.
BMC Cancer|May 21, 2017
The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patientsMatteo Lambertini, Paola Anserini, Valeria Fontana, et al.
JAMA|January 1, 2016
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical TrialMatteo Lambertini, Luca Boni, Andrea Michelotti, et al.
Cancer Treatment Reviews|February 5, 2023
Germline TP53 pathogenic variants and breast cancer: A narrative reviewEva Blondeaux, Luca Arecco, Kevin Punie, et al.
JCO Oncology Practice|October 9, 2025
Comprehensive Diagnostic and Therapeutic Approaches for Estrogen Receptor-Low Breast Cancer: A Multidisciplinary Perspective From Oncologists and PathologistsPaola Zagami, Andrea Botticelli, Isabella Castellano, et al.
British Journal of Cancer|November 2, 2016
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patientsMatteo Lambertini, Ana Catarina Pinto, Lieveke Ameye, et al.
Journal of the National Cancer Institute|December 1, 2021
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer PatientsMatteo Lambertini, Luca Boni, Andrea Michelotti, et al.
Breast Cancer Research and Treatment|April 28, 2025
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trialChristian Maurer, Elisa Agostinetto, Lieveke Ameye, et al.
Oncology Research and Treatment|December 6, 2022
Career and Professional Development for Young OncologistsMaximilian J Mair, Claudia Cardone, Liz Connolly, et al.
Breast (Edinburgh, Scotland)|November 22, 2017
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancerSamuel Martel, Elena Poletto, Arlindo R Ferreira, et al.
Pageof 38